BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25063204)

  • 1. Leucine stimulates ASCT2 amino acid transporter expression in porcine jejunal epithelial cell line (IPEC-J2) through PI3K/Akt/mTOR and ERK signaling pathways.
    Zhang S; Ren M; Zeng X; He P; Ma X; Qiao S
    Amino Acids; 2014 Dec; 46(12):2633-42. PubMed ID: 25063204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide.
    Bauchart-Thevret C; Cui L; Wu G; Burrin DG
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E899-909. PubMed ID: 20841502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
    Fuchs BC; Finger RE; Onan MC; Bode BP
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine stimulates procollagen alpha1(I) translation on hepatic stellate cells through ERK and PI3K/Akt/mTOR activation.
    Pérez de Obanos MP; López Zabalza MJ; Prieto J; Herraiz MT; Iraburu MJ
    J Cell Physiol; 2006 Nov; 209(2):580-6. PubMed ID: 16897753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of porcine glucagon-like peptides-2 on tight junction in GLP-2R + IPEC-J2 cell through the PI
    Qi KK; Sun YQ; Wan J; Deng B; Men XM; Wu J; Xu ZW
    J Anim Physiol Anim Nutr (Berl); 2017 Dec; 101(6):1242-1248. PubMed ID: 28158914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glutamine transport to suppress melanoma cell growth.
    Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
    Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide promotes apoptosis and oxidative injury of porcine small intestinal epithelial cells by down-regulating the expression of glutamine transporter ASCT2.
    Tang X; Xiong K; Liu J; Li M
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37410896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Leucine Promotes STAT1 and ISGs Expression in TGEV-Infected IPEC-J2 Cells
    Du J; Chen D; Yu B; He J; Yu J; Mao X; Luo Y; Zheng P; Luo J
    Front Immunol; 2021; 12():656573. PubMed ID: 34367129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine Affects α-Amylase Synthesis through PI3K/Akt-mTOR Signaling Pathways in Pancreatic Acinar Cells of Dairy Calves.
    Guo L; Liang Z; Zheng C; Liu B; Yin Q; Cao Y; Yao J
    J Agric Food Chem; 2018 May; 66(20):5149-5156. PubMed ID: 29733580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells.
    Pérez de Obanos MP; López-Zabalza MJ; Arriazu E; Modol T; Prieto J; Herraiz MT; Iraburu MJ
    Biochim Biophys Acta; 2007 Nov; 1773(11):1681-8. PubMed ID: 17707924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Regulatory Role of MeAIB in Protein Metabolism and the mTOR Signaling Pathway in Porcine Enterocytes.
    Tang Y; Tan B; Li G; Li J; Ji P; Yin Y
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498661
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liang Z; Yuan Z; Guo J; Wu J; Yi J; Deng J; Shan Y
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678035
    [No Abstract]   [Full Text] [Related]  

  • 17. L-Glutamine enhances enterocyte growth via activation of the mTOR signaling pathway independently of AMPK.
    Yi D; Hou Y; Wang L; Ouyang W; Long M; Zhao D; Ding B; Liu Y; Wu G
    Amino Acids; 2015 Jan; 47(1):65-78. PubMed ID: 25280462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acids regulate mTOR pathway and milk protein synthesis in a mouse mammary epithelial cell line is partly mediated by T1R1/T1R3.
    Wang Y; Liu J; Wu H; Fang X; Chen H; Zhang C
    Eur J Nutr; 2017 Dec; 56(8):2467-2474. PubMed ID: 27539583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
    Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.